Trial reportJournal of neuroengineering and rehabilitation2026
Eight weeks of focal muscle vibration shows improvements in muscle co-ordination and co-contraction in cerebral palsy children: a randomized control trial.
Trial report in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05751135 (Impact of Focal Muscle Vibration on Bio-psychosocial Outcomes in Cerebral Palsy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of Focal Muscle Vibration on Bio-psychosocial Outcomes in Cerebral Palsy
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundMuscle spasticity, impaired coordination and fatigue are common in cerebral palsy (CP) children. This study investigated frequency-specific effects of focal muscle vibration (FMV) on neuromuscular activation, fatigue, and agonist-antagonist coordination. We hypothesized that 8 weeks of FMV would improve lower limb muscle activation, reduce fatigue, and optimize co-contraction compared to control, with differential effects between 80 and 100 Hz stimulation.
methodsIn a double-blind randomized controlled trial, 65 spastic diplegic CP children (GMFCS II-IV) were allocated to Control, 80 Hz, or 100 Hz FMV groups. Primary outcomes were EMG-derived muscle activation (RMS) and fatigue (median frequency; and fatigue index). Secondary outcomes included co-contraction index (CCI) between tibialis anterior (TA) and soleus (Sol). Assessments were conducted at baseline, 4, 8, and 12 weeks. Linear mixed-effects models evaluated Group, Time, and Group × Time effects, with Bonferroni-corrected post-hoc comparisons.
resultsSignificant group differences were observed primarily in the TA. In non-dominant leg, the 100 Hz group showed higher RMS compared to Control at 4 weeks (p = 0.027) and 8 weeks (p = 0.027) and compared to 80 Hz at 4 weeks (p = 0.045) and 8 weeks (p = 0.008). In dominant leg, 100 Hz also demonstrated higher RMS than Control at 8 weeks (p = 0.003). Fatigue analysis revealed significant time effects in soleus muscle (p ≤ 0.009), with 100 Hz group demonstrating more sustained MDF values in the dominant limb, suggesting improved fatigue resistance, whereas 80 Hz group showed greater fatigue-related declines. FI analysis further revealed significant Group × Time interactions in non-dominant Sol (p = 0.008), with 80 Hz differing from Control (p = 0.019) and 100 Hz (p = 0.008) at 8 weeks. For co-contraction, a significant group effect was observed in the non-dominant limb (p = 0.034), indicating differences between intervention and control groups, although post-hoc comparisons were not significant.
conclusionFMV induces frequency-specific neuromuscular adaptations in CP children. 100 Hz stimulation appears more effective for enhancing short-term muscle activation and fatigue resistance, while 80 Hz may promote longer-term coordination changes. Trial registration Trial prospectively registered with United States clinical trial registry (clinicaltrials.gov), trial ID: NCT05751135.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.